Autologous and Allogeneic Cytotherapies for Large Knee (Osteo)Chondral Defects: Manufacturing Process Benchmarking and Parallel Functional Qualification

• Main Authors: Virginie Philippe (Author), Annick Jeannerat (Author), Cédric Peneveyre (Author), Sandra Jaccoud (Author), Corinne Scaletta (Author), Nathalie Hirt-Burri (Author), Philippe Abdel-Sayed (Author), Wassim Raffoul (Author), Salim Darwiche (Author), Lee Ann Applegate (Author), Robin Martin (Author), Alexis Laurent (Author)
• Format: Book
• Published: MDPI AG, 2023-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Cytotherapies are often necessary for the management of symptomatic large knee (osteo)-chondral defects. While autologous chondrocyte implantation (ACI) has been clinically used for 30 years, allogeneic cells (clinical-grade FE002 primary chondroprogenitors) have been investigated in translational s...